No to CF drug Orkambi at cost of €391 million over five years

No to CF drug Orkambi at cost of €391 million over five years
Deal or no deal? Orkambi

Funding denied despite CF sufferers pleas for access

The state’s drug assessment watchdog has recommended against funding the cystic fibrosis drug Orkambi – to which Irish CF sufferers have pleaded for access.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive​

Related Articles

More from The Business Post